VivereX® Negative Pressure Wound Therapy (NPWT) Makes Wound Treatment Easy And Effective

Negative pressure wound therapy (NPWT) is a well-established advanced therapy that has been successful in adjunctive management of acute and chronic wounds.

Several research studies have demonstrated that the use of NPWT not only significantly increases the granulation of tissue formation but also improves the speed of wound closure and the skin grafting outcomes.

The VivereX uses the latest technology to allow you to deliver NPWT to your patients in the comfort of their own home. It’s benefits include:

  • A single use, cansiter free, portable pump with a 10 day lifespan that will deliver up to 10 days of uninterrupted therapy
  • Delivery of the optimum pressure (120mm Hg) for wound healing
  • Visual indicators for air leak, dressing and battery change
  • Portable, canister free and small enough to be placed in a pocket or attached to clothing using its unique fixed clip system.
  • A multilayer silicone  sterilised dressing available in 8 different sizes allowing for an impressive exudate capacity.
  • A soft silicone layer to provide increased comfort at the wound contact layer that minimises disruption and trauma to the wound bed throughout the wear time and during dressing changes
  •  An efficient and quiet pump

Using the VivereX early in your patient’s wound care treatment plan can have significant benefits

  • Fewer wound dressing changes and less wastage
  • Fewer wound complications mean there is a lower likelihood of hospital readmittance
  • Cost savings for the HCP and the Patient versus Standard care
  • Allows for quicker transition of patient back into the community

The VivereX® patented NPWT technology allows the user to potentially heal quicker in the comfort of their own home.

Patient Experiences

Female born 1944
Patient presented with a ventral hernia after a VBG which was performed 25 years ago, this has consequently led to an accumulation of wound fluid. The fluid has been drained on multiple occasions. VivereX® was used and the wound was successfully closed after 2 days of treatment however, since there was additional fluid remaining, the wound had to be reopened and drained again. During the 2nd treatment session with VivereX®, there was no addition sign of fluid retention and the wound fully healed after 4 days.
Male born 1952
Patient was diagnosed with blistering erysipelas during December 2020, 1.5 weeks later a wound debridement of necrotic tissue was performed of an area of 12X12 (cm). Initially, the wound was treated with a competing device. The wound size did not decreased, therefore the current device was replaced by VivereX®. The patient expressed a substantial difference when compared to VivereX®; he felt that there was less leakage and tension during treatment with VivereX®.
Male, born 1948
Diabetic patient treated with combining insulin and oral drug therapy. Fell from a ladder on 12/8/2021 and an iron pipe penetrated his leg, which caused a 6X4 (cm) wound with a depth of 5 mm. On September 20th, 2021, a VivereX® device was applied and 3 days later the wound size had decreased to 5X4 (cm) and with a depth of 2-3 mm. 8 days later the wound has further decreased to 3.5X3.5 cm and with a depth of 1mm. The wound fully closed during the first week of December 2021.

Indications

  • Acute wound
  • Chronic wounds with minimal or medium volume of exudate, such as Chronic leg ulcer
  • Skin graft or flaps and donator site
  • Pressure ulcers
  • Diabetics ulcers
  • Surgical clean closed incision
  • Subacute dehisced wounds
  • Trauma wounds
  • Burn injury grade I and II
Product added to Quote successfully!
Continue Quote View Quote

X

Your Shopping cart

Close